Anti-human FLT3 monoclonal antibody that inhibits proliferation of monocytic leukemia cell line SHI-1

Hybridoma (Larchmt). 2011 Feb;30(1):61-7. doi: 10.1089/hyb.2010.0073.

Abstract

FLT3, a transmembrane molecule, was found on hematopoietic stem/progenitor cells and leukemia cells and determined to be a promising target in leukemia diagnosis and therapy. In this study a functional anti-human FLT3, monoclonal antibody (MAb) 10G6, was obtained and the specificity of this MAb was verified by flow cytometry. This MAb effectively recognized the FLT3 molecule expressed on a series of malignant cell lines. Furthermore, we demonstrated that MAb 10G6 inhibited the proliferation and migration ability and induced the apoptosis of SHI-1 cells that derived from a human monocytic leukemia. This functional anti-human FLT3 MAb provides a valuable tool for further study targeting the FLT3 on leukemia cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / pharmacology*
  • Antibody Specificity
  • Apoptosis / drug effects*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Flow Cytometry
  • Humans
  • Leukemia / drug therapy*
  • Leukemia / immunology
  • Monocytes / drug effects
  • Monocytes / physiology
  • fms-Like Tyrosine Kinase 3 / immunology*

Substances

  • Antibodies, Monoclonal
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3